Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan
· Delayed Price · Currency is TWD 46.20
-0.10 (-0.22%)
Apr 29, 2026, 1:30 PM CST
Orient EuroPharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,016 | 3,886 | 4,181 | 3,374 | 3,140 | 3,153 | Upgrade
|
| Market Cap Growth | -7.77% | -7.05% | 23.91% | 7.46% | -0.41% | -24.43% | Upgrade
|
| Enterprise Value | 6,257 | 5,718 | 8,267 | 7,274 | 6,427 | 5,292 | Upgrade
|
| Last Close Price | 46.30 | 44.80 | 47.35 | 37.45 | 34.85 | 34.12 | Upgrade
|
| PE Ratio | - | - | - | 23.44 | - | 26.24 | Upgrade
|
| PS Ratio | 0.87 | 0.85 | 0.95 | 0.74 | 0.66 | 0.66 | Upgrade
|
| PB Ratio | 0.55 | 0.53 | 0.72 | 0.81 | 0.91 | 0.91 | Upgrade
|
| P/TBV Ratio | 0.64 | 0.62 | 0.82 | 0.97 | 1.09 | 1.10 | Upgrade
|
| P/OCF Ratio | - | - | - | 52.18 | - | 40.61 | Upgrade
|
| EV/Sales Ratio | 1.36 | 1.24 | 1.88 | 1.58 | 1.36 | 1.11 | Upgrade
|
| EV/EBITDA Ratio | - | - | 53.87 | 30.85 | 913.23 | 87.72 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 103.01 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.44 | 0.44 | 0.73 | 1.16 | 1.46 | 1.22 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 21.15 | 16.88 | 112.21 | 44.25 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.16 | 0.45 | 0.71 | 0.92 | 0.63 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.57 | -7.57 | 17.07 | 12.49 | 447.95 | 36.16 | Upgrade
|
| Net Debt / FCF Ratio | -2.52 | -2.52 | -11.90 | -84.82 | -3.67 | -1.47 | Upgrade
|
| Asset Turnover | 0.39 | 0.39 | 0.39 | 0.43 | 0.48 | 0.54 | Upgrade
|
| Inventory Turnover | 2.16 | 2.16 | 2.10 | 2.00 | 2.26 | 2.15 | Upgrade
|
| Quick Ratio | 1.00 | 1.00 | 0.75 | 0.73 | 0.69 | 0.82 | Upgrade
|
| Current Ratio | 1.48 | 1.48 | 1.20 | 1.14 | 1.10 | 1.22 | Upgrade
|
| Return on Equity (ROE) | -7.29% | -7.29% | -4.63% | 4.45% | -8.57% | 2.02% | Upgrade
|
| Return on Assets (ROA) | -1.63% | -1.63% | -0.04% | 0.42% | -0.94% | -0.68% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.61% | -3.66% | -0.09% | 0.68% | -2.44% | -1.74% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.30% | -3.30% | -0.10% | 1.00% | -2.30% | -1.60% | Upgrade
|
| Earnings Yield | -14.13% | -14.60% | -6.79% | 4.27% | -9.90% | 3.81% | Upgrade
|
| FCF Yield | -11.60% | -11.99% | -5.27% | -1.03% | -27.32% | -47.10% | Upgrade
|
| Dividend Yield | 8.61% | 8.93% | 2.11% | 2.67% | - | 2.49% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 108.28% | Upgrade
|
| Buyback Yield / Dilution | - | - | 0.23% | -0.23% | 0.24% | 0.21% | Upgrade
|
| Total Shareholder Return | 8.61% | 8.93% | 2.34% | 2.44% | 0.24% | 2.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.